Antiviral response: Eosinophils active in immediate defense during influenza A infection
An atlas of HIV’s favorite targets in the blood of infected individuals
27 April 2021Only one in four people experience mild systemic side effects from COVID-19 vaccines
27 April 2021Antiviral response: Eosinophils active in immediate defense during influenza A infection
For the first time in published literature, Le Bonheur Children’s Hospital and University of Tennessee Health Science Center (UTHSC) researchers showed that a variety of white blood cells known as eosinophils modify the respiratory barrier during influenza A (IAV) infection, according to a recent paper in the journal Cells. This research could have implications in understanding SARS-CoV-2 (COVID-19) infection in asthmatic patients.
